Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.
about
Untangling tau imagingConnecting the dots between tau dysfunction and neurodegenerationTau-targeted treatment strategies in Alzheimer's diseaseEarly etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction?Tau and tauopathiesTau physiology and pathomechanisms in frontotemporal lobar degenerationTau promotes neurodegeneration via DRP1 mislocalization in vivoAnimal models for Alzheimer's disease and frontotemporal dementia: a perspectiveElectrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathyLoss of c-Jun N-terminal kinase-interacting protein-1 does not affect axonal transport of the amyloid precursor protein or Aβ production.Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease.Roles of tau protein in health and disease.Alzheimer's disease: insights from Drosophila melanogaster models.Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.The intersection of amyloid beta and tau at synapses in Alzheimer's diseaseSodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease modelsTau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice.The role of tau kinases in Alzheimer's disease.Is tau a suitable therapeutical target in tauopathies?The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeuticsModes of Aβ toxicity in Alzheimer's disease.ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice.Lessons from tau-deficient miceNo Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin MiceAlzheimer's disease models and functional genomics-How many needles are there in the haystack?Soluble forms of tau are toxic in Alzheimer's disease.The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice.Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylationPATHOLOGIES OF AXONAL TRANSPORT IN NEURODEGENERATIVE DISEASESWhat Renders TAU ToxicThe importance of tau phosphorylation for neurodegenerative diseasesSoluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.Aging in the nervous system of Caenorhabditis elegans.Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease.Brief update on different roles of tau in neurodegeneration.Biochemistry and cell biology of tau protein in neurofibrillary degenerationThe intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.Transport and diffusion of Tau protein in neurons.Axonal transport defects in Alzheimer's disease.Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium.
P2860
Q26739091-884AE719-4FFD-41AF-AA56-079DF2DEEB69Q26996848-66ED8A91-4BBF-445B-8540-79C4F1438DEBQ27023429-7832B765-0FB8-4754-8106-81B51BD81C44Q27026907-4FF292D3-86BA-4C6F-86F4-79F01F0728E7Q27027415-767299D6-1FEF-40C1-A28A-E234A0969434Q28070250-C0A8FD20-997C-42C0-AB9C-006013EBCDB1Q28119104-FDFAA576-3921-41F9-AABE-1998F3D42E4BQ28749702-8EB2A63F-7B3C-4E54-A004-B97907742EBEQ30528756-AB3F3514-6090-4238-BF6B-A92D6B17643BQ30564134-36017FE8-4E36-4FD1-95BF-66990ACD52F7Q30982773-60F24A29-A5E9-422B-9463-B4651FB303D9Q33559303-63D30CC0-6311-4191-8AFC-900C5BA171D3Q33799241-1FCCB95F-0400-4F5F-A48B-E1EBDFE72AA0Q33987984-74215861-C097-488A-BFE9-4F05C363C727Q34054680-35609D58-C7BF-4370-8572-FCB1D67774EEQ34068459-43A54644-489D-48B0-8DEC-2B04039052A1Q34102829-2A9A27C6-9D98-4835-958E-9DFAD811904FQ34138413-BF90241A-7FAE-4F53-B339-22A470CE7AE1Q34878802-60A585C6-99B5-44F9-80B6-36E579FA3A76Q35216140-938702EF-A1DC-4699-800A-B5EB01DED4D4Q35235869-EAA3940F-632B-4F2D-8B22-A69C3889973CQ35636403-D2CD19B9-0307-45C4-8922-05517B07B3D2Q36031983-1B6C7107-4290-4458-A88E-E345FCBA9238Q36162472-EE47DC01-517B-4651-A71C-D83AFBC6DFC8Q36193841-99571806-60C2-4C6B-9967-E9E893788807Q36286360-1E6309E5-90C6-4B73-857E-0192FC148519Q36666964-8BF698AD-FDD0-4CE6-8F56-58FF5AD142B7Q36840001-32492F37-4BE3-42FC-8CE0-F07EF094947EQ36907760-05F029B4-17E1-4096-BE8E-B725A94A83F8Q36914658-54A717E7-D38F-4A6D-A636-94B5A8D294A5Q36968220-1D5645C5-9231-4B7D-87F5-6D827D3EE08CQ37290158-6219A590-778C-4190-BBF2-3AC1B9A1EC29Q37313547-ADD30CD3-3E05-4D4F-A248-69EC075E5A8AQ37630546-59BD1B1A-BA95-49C7-9BB9-5E9DBA2E1AB8Q37893588-F34C46DD-FE1D-4C02-9536-E495D4D3A8B1Q38023859-DD5BCE82-C2C1-4111-A4B2-B0020D44DE9AQ38092945-C67C1B37-CDE7-4B99-8336-00E0C8F2395AQ38200941-35060BDC-AD77-449F-B5F2-035F38EC0BEDQ38232821-638B1A59-3539-4AFD-9C2A-4BA1BE59B421Q38715233-84E0D8E4-B64F-4B9D-A29B-7CBA8E81072E
P2860
Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phosphorylated Tau interacts w ...... 1 (JIP1) in Alzheimer disease.
@en
Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1
@nl
type
label
Phosphorylated Tau interacts w ...... 1 (JIP1) in Alzheimer disease.
@en
Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1
@nl
prefLabel
Phosphorylated Tau interacts w ...... 1 (JIP1) in Alzheimer disease.
@en
Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting protein 1
@nl
P2860
P50
P356
P1476
Phosphorylated Tau interacts w ...... 1 (JIP1) in Alzheimer disease.
@en
P2860
P304
20909-20916
P356
10.1074/JBC.M109.014472
P407
P577
2009-06-02T00:00:00Z